Mucoadhesive nanomedicines: Characterization and modulation of mucoadhesion at the nanoscale

Expert Opinion on Drug Delivery

Volumn 8, Issue 8, 2011, Pages 1085-1104

  Das Neves, José ^a   Bahia, Maria Fernanda ^a   Amiji, Mansoor M ^b   Sarmento, Bruno ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

Cytoadhesion; Mucosal surfaces; Mucus; Nanotechnology; Polymeric nanoparticles

Indexed keywords

ALGINIC ACID; GLYCOCONJUGATE; LECTIN; MACROGOL; MUCIN; NANOPARTICLE; POLYACRYLIC ACID; POLYMER;

ADSORPTION; ANALYTIC METHOD; ATOMIC FORCE MICROSCOPY; COMPLEX FORMATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; IN VIVO STUDY; INFRARED SPECTROSCOPY; METHODOLOGY; MICROGRAVIMETRY; MOLECULAR INTERACTION; MUCOADHESION; NANOMEDICINE; NONHUMAN; OPTICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SURFACE PROPERTY; VIRUS LIKE AGENT;

ADHESIVES; HUMANS; MUCOUS MEMBRANE; NANOMEDICINE;

EID: 79960799453     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.586334     Document Type: Review

References (138)

1. Good RJ. On the definition of adhesion. J Adhes 1976;8(1):1-9
2. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005;57(11):1556-68 (Pubitemid 41443469)
3. Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther 2002;2(3):287-98 (Pubitemid 34464810)
4. Davidovich-Pinhas M, Bianco-Peled H. Mucoadhesion: a review of characterization techniques. Expert Opin Drug Deliv 2010;7(2):259-71
5. Roy K, Mao HQ, Huang SK, et al. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5(4):387-91 (Pubitemid 29180575)
6. Sakuma S, Sudo R, Suzuki N, et al. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int J Pharm 1999;177(2):161-72 (Pubitemid 29073412)
7. Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007;24(12):2198-206 (Pubitemid 350060707)
8. Sarmento B, Ribeiro A, Veiga F, et al. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 2007;8(10):3054-60 (Pubitemid 350011625)
9. Shen J, Wang Y, Ping Q, et al. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009;137(3):217-23
10. Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997;14(3):259-66 (Pubitemid 27160935)
11. Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. Br J Ind Med 1980;37(4):337-62 (Pubitemid 11215084)
12. Dawson M, Wirtz D, Hanes J. Enhanced viscoelasticity of human ystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem 2003;278(50):50393-401 (Pubitemid 37548883)
13. Lai SK, Wang YY, Wirtz D, et al. Micro- and macrorheology of mucus. Adv Drug Deliv Rev 2009;61(2):86-100
14. Accili D, Menghi G, Bonacucina G, et al. Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur J Pharm Sci 2004;22(4):225-34 (Pubitemid 38758009)
15. Lindemann J, Leiacker R, Rettinger G, et al. Nasal mucosal temperature during respiration. Clin Otolaryngol Allied Sci 2002;27(3):135-9 (Pubitemid 34779633)
16. Fujishima H, Toda I, Yamada M, et al. Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol 1996;80(1):29-32 (Pubitemid 26017555)
17. Girardin F, Orgul S, Erb C, et al. Relationship between corneal temperature and finger temperature. Arch Ophthalmol 1999;117(2):166-9 (Pubitemid 29091809)
18. Sund-Levander M, Forsberg C, Wahren LK. Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review. Scand J Caring Sci 2002;16(2):122-8 (Pubitemid 34534246)
19. Evans DF, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29(8):1035-41
20. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992;27(1-2):57-92
21. Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci 2006;11(2-3):164-70 (Pubitemid 43867390)
22. Varum FJ, Veiga F, Sousa JS, et al. An investigation into the role of mucus thickness on mucoadhesion in the gastrointestinal tract of pig. Eur J Pharm Sci 2010;40(4):335-41
23. Cone RA. Mucus. In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L, editors, Mucosal immunol. 3rd edition. Academic Press, San Diego, CA; 2005. p. 49-72
24. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev 2009;61(2):75-85
25. Jubeh TT, Barenholz Y, Rubinstein A. Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm Res 2004;21(3):447-53 (Pubitemid 38338980)
26. Lee S, Muller M, Rezwan K, et al. Porcine gastric mucin (PGM) at the water/poly(dimethylsiloxane) (PDMS) interface: influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties. Langmuir 2005;21(18):8344-53 (Pubitemid 41321809)
27. Yudin AI, Hanson FW, Katz DF. Human cervical mucus and its interaction with sperm: a fine-structural view. Biol Reprod 1989;40(3):661-71 (Pubitemid 19149772)
28. Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J 2001;81(4):1930-7 (Pubitemid 32917145)
29. Lai SK, O'Hanlon DE, Harrold S, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 2007;104(5):1482-7 (Pubitemid 46214616)
30. Lai SK, Wang YY, Hida K, et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA 2010;107(2):598-603
31. Willits RK, Saltzman WM. Synthetic polymers alter the structure of cervical mucus. Biomaterials 2001;22(5):445-52 (Pubitemid 32007849)
32. McGill S, Smyth H. Disruption of the mucus barrier by topically applied exogenous particles. Mol Pharm 2010;7(6):2280-8
33. Peppas NA, Sahlin JJ. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996;17(16):1553-61 (Pubitemid 26289741)
34. Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical aspects ofbioadhesive systems for drug administration. Drug Dev Ind Pharm 1988;14(2-3):283-318
35. Lehr CM, Bouwstra JA, Kok W, et al. Bioadhesion by means of specific binding of tomato lectin. Pharm Res 1992;9(4):547-53
36. Woodley J. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet 2001;40(2):77-84 (Pubitemid 32242791)
37. Johnson KL, Kendall K, Roberts D. Surface energy and the contact of elastic solids. Proc R Soc Lond A 1971;324(1558):301-13
38. Carrillo JM, Raphael E, Dobrynin AV. Adhesion of nanoparticles. Langmuir 2010;26(15):12973-9
39. Durrer C, Irache JM, Puisieux F, et al. Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies. Pharm Res 1994;11(5):680-3 (Pubitemid 24171762)
40. Serra L, Domenech J, Peppas NA. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm 2009;71(3):519-28
41. Bridges JF, Woodley JF, Duncan R, et al. Soluble N-(2-hydroxypropyl) methacrylamide copolymers as a potential oral, controlled-release, drug delivery system. I: bioadhesion to the rat intestine in vitro. Int J Pharm 1988;44(1-3):213-23
42. Irachea JM, Durrer C, Duchene D, et al. In vitro study of lectin-latex conjugates for specific bioadhesion. J Control Release 1994;31(2):181-8
43. Lehr CM. Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release 2000;65(1-2):19-29
44. Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005;57(11):1569-82 (Pubitemid 41443470)
45. Hoyer H, Hombach J, Perera G, et al. Synthesis and in vitro characterization of a novel PAA-ATP conjugate. Drug Dev Ind Pharm 2011;37(3):300-9
46. Kharenko EA, Larionova NI, Demina NB. Mucoadhesive drug delivery systems [review]. Pharm Chem J 2009;43(4):200-8
47. Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm 2005;60(1):1-16 (Pubitemid 40545855)
48. Tamburic S, Craig DQM. A comparison of different in vitro methods for measuring mucoadhesive performance. Eur J Pharm Biopharm 1997;44(2):159-67 (Pubitemid 28539151)
49. Grabovac V, Guggi D, Bernkop-Schnurch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 2005;57(11):1713-23 (Pubitemid 41443475)
50. das Neves J, Amaral MH, Bahia MF. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm 2008;69(2):622-32
51. Edsman K, Hagerstrom H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57(1):3-22 (Pubitemid 40030097)
52. Hagerstrom H, Bergstrom CA, Edsman K. The importance of gel properties for mucoadhesion measurements: a multivariate data analysis approach. J Pharm Pharmacol 2004;56(2):161-8 (Pubitemid 38232745)
53. Takeuchi H, Thongborisute J, Matsui Y, et al. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 2005;57(11):1583-94 (Pubitemid 41443471)
54. Mugabe C, Hadaschik BA, Kainthan RK, et al. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy. BJU Int 2009;103(7):978-86
55. Jintapattanakit A, Junyaprasert VB, Kissel T. The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake. J Pharm Sci 2009;98(12):4818-30
56. Svensson O, Thuresson K, Arnebrant T. Interactions between drug delivery particles and mucin in solution and at interfaces. Langmuir 2008;24(6):2573-9 (Pubitemid 351542659)
57. Durrer C, Irache JM, Duchene D, et al. Mucin interactions with functionalized polystyrene latexes. J Colloid Interface Sci 1995;170(2):555-61
58. Ezpeleta I, Arangoa MA, Irache JM, et al. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus. Int J Pharm 1999;191(1):25-32 (Pubitemid 29502174)
59. Wang X, Zheng C, Wu Z, et al. Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res Part B Appl Biomater 2009;88(1):150-61
60. Lopedota A, Trapani A, Cutrignelli A, et al. The use of Eudragit RS® 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur J Pharm Biopharm 2009;72(3):509-20
61. Ramteke S, Ganesh N, Bhattacharya S, et al. Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori. J Drug Target 2008;16(9):694-705
62. Chayed S, Winnik FM. In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur J Pharm Biopharm 2007;65(3):363-70 (Pubitemid 46321599)
63. Marx KA. Quartz crystal microbalance: a useful tool for studying thin polymer films and complex biomolecular systems at the solution-surface interface. Biomacromolecules 2003;4(5):1099-120 (Pubitemid 37184619)
64. Santos NC, Castanho MA. An overview of the biophysical applications of atomic force microscopy. Biophys Chem 2004;107(2):133-49 (Pubitemid 38220955)
65. Patel D, Smith JR, Smith AW, et al. An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. Int J Pharm 2000;200(2):271-7 (Pubitemid 30364914)
66. Cleary J, Bromberg L, Magner E. Adhesion of polyether-modified poly (acrylic acid) to mucin. Langmuir 2004;20(22):9755-62
67. Iijima M, Yoshimura M, Tsuchiya T, et al. Direct measurement of interactions between stimulation-responsive drug delivery vehicles and artificial mucin layers by colloid probe atomic force microscopy. Langmuir 2008;24(8):3987-92 (Pubitemid 351569001)
68. Svensson O, Thuresson K, Arnebrant T. Interactions between chitosan-modified particles and mucin-coated surfaces. J Colloid Interface Sci 2008;325(2):346-50
69. Lamprecht A, Koenig P, Ubrich N, et al. Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells. Nanotechnology 2006;17(15):3673-80 (Pubitemid 44424393)
70. Zourob M, Elwary S, Fan X, et al. Label-free detection with the resonant mirror biosensor. Methods Mol Biol 2009;503:89-138
71. Suh J, Choy KL, Lai SK, et al. PEGylation of nanoparticles improves their cytoplasmic transport. Int J Nanomedicine 2007;2(4):735-41
72. Norris DA, Sinko PJ. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci 1997;63(11):1481-92 (Pubitemid 127598331)
73. Sanders NN, De Smedt SC, Van Rompaey E, et al. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med 2000;162(5):1905-11
74. Shen H, Hu Y, Saltzman WM. DNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagents. Biophys J 2006;91(2):639-44
75. Cu Y, Saltzman WM. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm 2009;6(1):173-81
76. Cu Y, Saltzman WM. Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev 2009;61(2):101-14
77. Boukari H, Brichacek B, Stratton P, et al. Movements of HIV-virions in human cervical mucus. Biomacromolecules 2009;10(9):2482-8
78. Dawson M, Krauland E, Wirtz D, et al. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog 2004;20(3):851-7 (Pubitemid 38784024)
79. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009;83(21):11196-200
80. Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol Biosci 2010;10(12):1473-83
81. Suh J, Dawson M, Hanes J. Real-time multiple-particle tracking: applications to drug and gene delivery. Adv Drug Deliv Rev 2005;57(1):63-78 (Pubitemid 39424064)
82. Makhlof A, Werle M, Tozuka Y, et al. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J Control Release 2011;149(1):81-8
83. Prego C, Fabre M, Torres D, et al. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006;23(3):549-56
84. Wirth M, Kneuer C, Lehr CM, et al. Lectin-mediated drug delivery: discrimination between cytoadhesion and cytoinvasion and evidence for lysosomal accumulation of wheat germ agglutinin in the Caco-2 model. J Drug Target 2002;10(6):439-48 (Pubitemid 35230193)
85. Fillafer C, Friedl DS, Wirth M, et al. Fluorescent bionanoprobes to characterize cytoadhesion and cytoinvasion. Small 2008;4(5):627-33 (Pubitemid 351808061)
86. Pimienta C, Lenaerts V, Cadieux C, et al. Mucoadhesion of hydroxypropylmethacrylate nanoparticles to rat intestinal ileal segments in vitro. Pharm Res 1990;7(1):49-53 (Pubitemid 20115798)
87. Pimienta C, Chouinard F, Labib A, et al. Effect of various poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow. Int J Pharm 1992;80(1):1-8
88. Bernkop-Schnurch A, Weithaler A, Albrecht K, et al. Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int J Pharm 2006;317(1):76-81 (Pubitemid 43866341)
89. Sajeesh S, Sharma CP. Novel polyelectrolyte complexes based on poly (methacrylic acid)-bis(2-aminopropyl) poly(ethylene glycol) for oral protein delivery. J Biomater Sci Polym Ed 2007;18(9):1125-39 (Pubitemid 47556678)
90. Sandri G, Bonferoni MC, Rossi S, et al. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm 2007;65(1):68-77 (Pubitemid 44827693)
91. Kawashima Y, Yamamoto H, Takeuchi H, et al. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 2000;5(1):77-85 (Pubitemid 30069202)
92. Bravo-Osuna I, Vauthier C, Farabollini A, et al. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007;28(13):2233-43 (Pubitemid 46216448)
93. De Campos AM, Sanchez A, Gref R, et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003;20(1):73-81 (Pubitemid 37103234)
94. Durrer C, Irache JM, Puisieux F, et al. Mucoadhesion of latexes. I. Analytical methods and kinetic studies. Pharm Res 1994;11(5):674-9 (Pubitemid 24171761)
95. Henning A, Schneider M, Bur M, et al. Embryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airways. AAPS PharmSciTech 2008;9(2):521-7
96. Henning A, Schneider M, Nafee N, et al. Influence of particle size and material properties on mucociliary clearance from the airways. J Aerosol Med Pulm Drug Deliv 2010;23(4):233-41
97. Arangoa MA, Campanero MA, Renedo MJ, et al. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm Res 2001;18(11):1521-7 (Pubitemid 33022406)
98. Arbos P, Arangoa MA, Campanero MA, et al. Quantification of the bioadhesive properties of protein-coated PVM/ MA nanoparticles. Int J Pharm 2002;242(1-2):129-36
99. Umamaheshwari RB, Ramteke S, Jain NK. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model. AAPS PharmSciTech 2004;5(2):e32
100. Takeuchi H, Matsui Y, Sugihara H, et al. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 2005;303(1-2):160-70 (Pubitemid 41318033)
101. Thirawong N, Thongborisute J, Takeuchi H, et al. Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release 2008;125(3):236-45
102. Agueros M, Areses P, Campanero MA, et al. Bioadhesive properties and biodistribution of cyclodextrin-poly (anhydride) nanoparticles. Eur J Pharm Sci 2009;37(3-4):231-40
103. Kreuter J, Muller U, Munz K. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. Int J Pharm 1989;55(1):39-45 (Pubitemid 19247499)
104. Sajeesh S, Sharma CP. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm 2006;325(1-2):147-54 (Pubitemid 44573692)
105. Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30(29):5691-700
106. Steingoetter A, Kunz P, Weishaupt D, et al. Analysis of the meal-dependent intragastric performance of a gastric-retentive tablet assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003;18(7):713-20 (Pubitemid 37271837)
107. Choy YB, Park JH, McCarey BE, et al. Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci 2008;49(11):4808-15
108. Kremser C, Albrecht K, Greindl M, et al. In vivo determination of the time and location of mucoadhesive drug delivery systems disintegration in the gastrointestinal tract. Magn Reson Imaging 2008;26(5):638-43
109. Mauck CK, Katz D, Sandefer EP, et al. Vaginal distribution of Replens and K-Y Jelly using three imaging techniques. Contraception 2008;77(3):195-204
110. Agueros M, Zabaleta V, Espuelas S, et al. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J Control Release 2010;145(1):2-8
111. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26(5):1025-58
112. Sakuma S, Hayashi M, Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 2001;47(1):21-37 (Pubitemid 32209230)
113. Bernkop-Schnurch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000;194(1):1-13
114. Sandri G, Bonferoni MC, Rossi S, et al. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties. AAPS PharmSciTech 2010;11(1):362-71
115. Takeuchi H, Matsui Y, Yamamoto H, et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003;86(2-3):235-42 (Pubitemid 36084273)
116. Carreno-Gomez B, Woodley JF, Florence AT. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int J Pharm 1999;183(1):7-11 (Pubitemid 29248818)
117. Liu Y, Wang P, Sun C, et al. Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers. Int J Pharm 2010;397(1-2):155-63
118. Yamamoto H, Kuno Y, Sugimoto S, et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 2005;102(2):373-81 (Pubitemid 40093760)
119. Grabovac V, Bernkop-Schnurch A. Development and in vitro evaluation of surface modified poly(lactide-coglycolide) nanoparticles with chitosan-4-thiobutylamidine. Drug Dev Ind Pharm 2007;33(7):767-74 (Pubitemid 47123803)
120. Moghaddam FA, Atyabi F, Dinarvand R. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomedicine 2009;5(2):208-15
121. Wang YY, Lai SK, Suk JS, et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl 2008;47(50):9726-9
122. Tang BC, Dawson M, Lai SK, et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci USA 2009;106(46):19268-73
123. De Ascentiis A, DeGrazia JL, Bowman CN, et al. Mucoadhesion of poly(2-hydroxyethyl methacrylate) is improved when linear poly(ethylene oxide) chains are added to the polymer network. J Control Release 1995;33(1):197-201
124. Ponchel G, Montisci MJ, Dembri A, et al. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm 1997;44(1):25-31 (Pubitemid 28298772)
125. Lai SK, Wang YY, Cone R, et al. Altering mucus rheology to "solidify" human mucus at the nanoscale. PLoS ONE 2009;4(1):e4294
126. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009;61(2):158-71
127. Suk JS, Lai SK, Wang YY, et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 2009;30(13):2591-7
128. Yamanaka YJ, Leong KW. Engineering strategies to enhance nanoparticle-mediated oral delivery. J Biomater Sci Polym Ed 2008;19(12):1549-70
129. Lamprecht A, Yamamoto H, Takeuchi H, et al. A pH-sensitive microsphere system for the colon deliveryof tacrolimus containing nanoparticles. J Control Release 2005;104(2):337-46 (Pubitemid 40724934)
130. Bhavsar MD, Amiji MM. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 2007;119(3):339-48 (Pubitemid 46770879)
131. Sakloetsakun D, Perera G, Hombach J, et al. The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate. AAPS PharmSciTech 2010;11(3):1185-92
132. Champion JA, Katare YK, Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc Natl Acad Sci USA 2007;104(29):11901-4 (Pubitemid 47185602)
133. Decuzzi P, Ferrari M. The receptor-mediated endocytosis of nonspherical particles. Biophys J 008;94(10):3790-7
134. Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009;26(1):244-9
135. Madsen F, Eberth K, Smart JD. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. J Control Release 1998;50(1-3):167-78 (Pubitemid 28044111)
136. Rossi S, Ferrari F, Bonferoni MC, et al. Characterization of chitosan hydrochloride-mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio. Eur J Pharm Sci 2001;12(4):479-85 (Pubitemid 32166747)
137. Sriamornsak P, Wattanakorn N. Rheological synergy in aqueous mixtures of pectin and mucin. Carbohydr Polym 2008;74(3):474-81
138. Butt HJ, Cappella B, Kappl M. Force measurements with the atomic force microscope: Technique, interpretation and applications. Surf Sci Rep 2005;59(1-6):1-152 (Pubitemid 41594664)